KalVista Pharmaceuticals Ownership | Who Owns KalVista Pharmaceuticals?
KalVista Pharmaceuticals Ownership Summary
KalVista Pharmaceuticals is owned by 110.66% institutional investors, 1.27% insiders. Vr adviser is the largest institutional shareholder, holding 14.34% of KALV shares. American Funds SMALLCAP World A is the top mutual fund, with 7.81% of its assets in KalVista Pharmaceuticals shares.
KALV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | KalVista Pharmaceuticals | 110.66% | 1.27% | -11.93% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vr adviser | 6.25M | 14.34% | $73.62M |
| Tang capital management | 4.22M | 9.68% | $49.70M |
| Suvretta capital management | 4.19M | 9.62% | $49.38M |
| Frazier life sciences management | 3.69M | 8.46% | $43.44M |
| Capital world investors | 3.23M | 7.40% | $38.02M |
| Blackrock | 2.95M | 6.76% | $34.69M |
| Vestal point capital, lp | 2.30M | 5.28% | $27.09M |
| Adage capital partners gp | 2.05M | 4.70% | $24.15M |
| Vanguard group | 1.99M | 4.57% | $23.45M |
| Boxer capital | 1.59M | 3.65% | $18.73M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 4.22M | 5.06% | $49.70M |
| Saturn v capital management | 1.13M | 5.02% | $13.29M |
| Vr adviser | 6.25M | 4.69% | $73.62M |
| Rosalind advisors | 337.99K | 3.06% | $3.98M |
| Great point partners | 1.34M | 3.02% | $15.77M |
| Nan fung group | 219.28K | 2.76% | $2.58M |
| Dafna capital management | 806.97K | 2.27% | $9.51M |
| Frazier life sciences management | 3.69M | 2.03% | $43.44M |
| First turn management | 1.06M | 2.03% | $12.48M |
| Vestal point capital, lp | 2.30M | 2.02% | $27.09M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | 3.23M | 0.01% | 1.76M |
| Vestal point capital, lp | 2.30M | 2.02% | 1.65M |
| Great point partners | 1.34M | 3.02% | 1.34M |
| Blackrock | 2.95M | 0.00% | 512.88K |
| Vanguard group | 1.99M | 0.00% | 305.48K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | - | - | -1.16M |
| Stempoint capital lp | - | - | -736.76K |
| Marshall wace, llp | 48.91K | 0.00% | -579.98K |
| Driehaus capital management | - | - | -535.72K |
| Adage capital partners gp | 2.05M | 0.04% | -525.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Great point partners | 1.34M | 3.02% | 1.34M | $15.77M |
| Norges bank | 131.30K | 0.00% | 131.30K | $1.55M |
| Russell investments group | 78.68K | 0.00% | 78.68K | $926.87K |
| Advisor group | 21.38K | 0.00% | 21.38K | $251.86K |
| Corebridge financial | 20.49K | 0.00% | 20.49K | $241.36K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Farther finance advisors | -13.00 |
| Gamma investing | -16.00 |
| Innealta capital | -30.00 |
| Quadrant capital group | -81.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 122 | -7.58% | 48,235,227 | 2.65% | 110 | 0.95% | 63 | -20.25% | 33 | -8.33% |
| Mar 31, 2024 | 132 | 24.53% | 46,987,795 | 27.12% | 107 | 0.95% | 79 | 25.40% | 36 | 80.00% |
| Dec 31, 2023 | 106 | -4.50% | 36,964,765 | 1.93% | 106 | 0.97% | 63 | 18.87% | 20 | -23.08% |
| Sep 30, 2023 | 111 | 13.27% | 36,263,336 | 5.26% | 104 | 1.05% | 53 | 6.00% | 26 | 4.00% |
| Jun 30, 2023 | 98 | 10.11% | 34,451,525 | 2.17% | 100 | 1.04% | 50 | 28.21% | 25 | -16.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 3.37M | 7.81% | 146.44K |
| Vanguard Total Stock Mkt Idx Inv | 1.20M | 2.78% | - |
| iShares Russell 2000 ETF | 976.65K | 2.26% | -2.20K |
| Vanguard Institutional Extnd Mkt Idx Tr | 565.02K | 1.31% | 2.46K |
| SPDR® S&P Biotech ETF | 483.39K | 1.12% | 5.35K |
| International Biotechnology Ord | 431.23K | 1.00% | -36.77K |
| Fidelity Small Cap Index | 388.73K | 0.90% | -9.93K |
| MEDICAL BioHealth EUR Acc | 382.67K | 0.89% | - |
| Emerald Growth A | 352.99K | 0.82% | 74.73K |
| iShares Russell 2000 Growth ETF | 348.27K | 0.81% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 18, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | $133.29K |
| Nov 18, 2024 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sell | $66.57K |
| Nov 18, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | $74.77K |
| Sep 09, 2024 | Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sell | $89.62K |
| Aug 23, 2024 | Audhya Paul K. | CHIEF MEDICAL OFFICER | Sell | $26.47K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 6 |
| 2024 Q2 | - | 5 |
| 2024 Q1 | 21 | 16 |
| 2023 Q4 | 3 | 6 |
KALV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools